Literature DB >> 3094652

Campylobacter pyloridis: what role in gastritis and peptic ulcer.

A T Axon.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3094652      PMCID: PMC1341566          DOI: 10.1136/bmj.293.6550.772

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Campylobacter pyloridis--a new factor in peptic ulcer disease?

Authors:  B J Rathbone; J I Wyatt; R V Heatley
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

2.  Epidemic gastritis with hypochlorhydria.

Authors:  E J Ramsey; K V Carey; W L Peterson; J J Jackson; F K Murphy; N W Read; K B Taylor; J S Trier; J S Fordtran
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

3.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

4.  Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis.

Authors:  H J O'Connor; A T Axon; M F Dixon
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

5.  Immune response to Campylobacter pyloridis in patients with peptic ulceration.

Authors:  J Kaldor; W Tee; P McCarthy; J Watson; B Dwyer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

6.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

7.  Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; S E Shires; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

  7 in total
  9 in total

1.  Use of an open-access gastroscopy service by a general practice: findings and subsequent specialist referral rate.

Authors:  A S Hungin
Journal:  J R Coll Gen Pract       Date:  1987-04

2.  Campylobacter associated gastritis in patients with non-ulcer dyspepsia.

Authors:  R J Loffeld; H V Potters; J W Arends; E Stobberingh; J A Flendrig; J P van Spreeuwel
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

3.  Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore.

Authors:  J Y Kang; A Wee; M V Math; R Guan; H H Tay; I Yap; I H Sutherland
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 4.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

5.  Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns.

Authors:  R J Owen; M Costas; D D Morgan; S L On; L R Hill; A D Pearson; D R Morgan
Journal:  Antonie Van Leeuwenhoek       Date:  1989-03       Impact factor: 2.271

6.  Helicobacter pylori and gastric acid output in peptic ulcer disease.

Authors:  J Y Kang; A Wee
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

7.  Influence of Helicobacter pylori on tryptase and cathepsin D in peptic ulcer.

Authors:  M Plebani; D Basso; M Rugge; F Vianello; F Di Mario
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

8.  Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy.

Authors:  R J Loffeld; B C Loffeld; J W Arends; J A Flendrig; J P van Spreeuwel
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

9.  Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.

Authors:  R J Loffeld; H V Potters; E Stobberingh; J A Flendrig; J P van Spreeuwel; J W Arends
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.